Articles

Molecular response assessment by quantitative real-time polymerase chain reaction after induction therapy in NPM1-mutated patients identifies those at high risk of relapse

Department of Medicine III, University Hospital Grosshadern, Munich, Germany
Department of Medicine III, University Hospital Grosshadern, Munich, Germany
Institute of Medical Informatics, Biometry and Epidemiology (IBE), Faculty of Medicine, Ludwig Maximilian University of Munich, Germany
Department of Medicine III, University Hospital Grosshadern, Munich, Germany
Department of Medicine III, University Hospital Grosshadern, Munich, Germany
Department of Medicine III, University Hospital Grosshadern, Munich, Germany
Department of Medicine III, University Hospital Grosshadern, Munich, Germany
Department of Hematology and Oncology, Barmherzige Brüder Hospital, Regensburg, Germany
Department of Molecular Medicine and Pathology, Faculty of Medical and Health Sciences, University of Auckland, New Zealand
Department of Medicine III, University Hospital Grosshadern, Munich, Germany;Clinical Cooperation Group Immunotherapy, Helmholtz Zentrum Munich, German Research Center for Environmental Health, Munich, Germany
Institute of Biostatistics and Clinical Research, University of Muenster, Germany
Department of Medicine A, Hematology and Oncology, University of Muenster, Germany
Department of Medicine A, Hematology and Oncology, University of Muenster, Germany
German Society of Hematology and Oncology, Berlin, Germany
Department of Medicine III, University Hospital Grosshadern, Munich, Germany
Department of Medicine III, University Hospital Grosshadern, Munich, Germany;Clinical Cooperation Group Leukemia, Helmholtz Zentrum Munich, German Research Center for Environmental Health, Munich, Germany
Vol. 99 No. 8 (2014): August, 2014 https://doi.org/10.3324/haematol.2014.104133